1026367-79-2

Upstream product

• 106-41-2 4-bromo-phenol 
• 136590-83-5 3,5-dichloropyridine-4-carboxaldehyde 

Downstream Products

• 251993-21-2 methyl 4-(4-bromophenoxy)thieno[2,3-c]pyridine-2-carboxylate 
• 251996-65-3 4-{4-[2-(2-morpholin-4-yl-ethylcarbamoyl)-vinyl]-phenoxy}-thieno[2,3-c]pyridine-2-carboxylic acid methyl ester 
• 1026447-41-5 4-(4-{2-[2-(1H-imidazol-4-yl)-ethylcarbamoyl]-vinyl}-phenoxy)-thieno[2,3-c]pyridine-2-carboxylic acid methyl ester 
• 1025840-46-3 4-[4-(2-morpholin-4-yl-ethylcarbamoyl)-phenoxy]-thieno[2,3-c]pyridine-2-carboxylic acid 
• 251996-61-9 methyl 4-[4-({[2-(4-morpholinyl)ethyl]amino}carbonyl)phenoxy]thieno[2,3-c]pyridine-2-carboxylate 
• 251996-66-4 methyl 4-(4-{(E)-3-[(2,3-Dihydroxypropyl)amino]-3-oxo-1-propenyl}phenoxy)thieno[2,3-c]pyridine-2-carboxylate 

Relevant academic research and scientific papers

Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(Aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamides

The elevated expression of cell adhesion molecules (CAMs) on the lumenal surface of vascular endothelial cells is a critical early event in the complex inflammatory process. The adhesive interactions of these CAMs that include E-selectin, ICAM-1, and VCAM